Expert Review of Clinical Pharmacology, Volume 10, Issue 5 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Clinical Pharmacology, Volume 10, Issue 5 (2017)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Volume 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Editorial

Editorial
Emerging therapies for NASH - the future is now
Andreas Geier & Monika Rau
Pages: 467-469
Published online: 20 Apr 2017
First Page PreviewforEmerging therapies for NASH - the future is now | Full Text | References | PDF (272.1 KB)
  • 4815 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis
Xiaoping Zhang, Ya-Chi Chen & Kimio Terao
Pages: 471-482
Published online: 15 Mar 2017
AbstractforClinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis | Full Text | References | PDF (1.1 MB)
  • 504 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Pirfenidone for the treatment of idiopathic pulmonary fibrosis
Peter M George & Athol U Wells
Pages: 483-491
Published online: 07 Mar 2017
AbstractforPirfenidone for the treatment of idiopathic pulmonary fibrosis | Full Text | References | PDF (1 MB)
  • 978 Views
  • 28 CrossRef citations
  • 0Altmetric

Review

Review
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options)
Ronald G. Hall 2nd, Michael Thatcher, Wei Wei, Shibin Varghese, Lincy Varughese, Michelle Ndiulor & Kenna D. Payne
Pages: 493-508
Published online: 15 Mar 2017
AbstractforDosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options) | Full Text | References | PDF (1.1 MB)
  • 281 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges
Joanna Dobroszycki, Philip Lee, Dina L. Romo, Michael G Rosenberg, Andrew Wiznia & Jacobo Abadi
Pages: 509-516
Published online: 14 Mar 2017
AbstractforAntiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges | Full Text | References | PDF (906.7 KB)
  • 174 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure
Justyna Krzysztofik & Piotr Ponikowski
Pages: 517-534
Published online: 30 Mar 2017
AbstractforCurrent and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure | Full Text | References | PDF (2.5 MB)
  • 406 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes
Simona Cernea, Avivit Cahn & Itamar Raz
Pages: 535-547
Published online: 06 Mar 2017
AbstractforPharmacological management of nonalcoholic fatty liver disease in type 2 diabetes | Full Text | References | PDF (1 MB)
  • 916 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
Allison A. Aka, Jeff A. Rappaport, Amanda M. Pattison, Takami Sato, Adam E. Snook & Scott A. Waldman
Pages: 549-557
Published online: 10 Apr 2017
AbstractforGuanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer | Full Text | References | PDF (999.2 KB)
  • 416 Views
  • 23 CrossRef citations
  • 0Altmetric

Original Research

Article
Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX
George P. Kim, Monika F. Parisi, Manish B. Patel, Corey L. Pelletier & Kathy W. Belk
Pages: 559-565
Published online: 19 Apr 2017
AbstractforComparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX | Full Text | References | PDF (799.9 KB)
  • 334 Views
  • 18 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

CSL112 and HDL function hypothesis – a never-ending wait
Muhammad Adnan Zaman et al.
Editorial | Published online: 15 Jul 2024
Free Access
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis
Neslihan Akdogan et al.
Article | Published online: 12 Jul 2024
Considerations when prescribing opioid agonist therapies for people living with HIV
Adati Tarfa et al.
Review Article | Published online: 4 Jul 2024
An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV)
Rebecca Y. Linfield et al.
Review Article | Published online: 30 Jun 2024
View all latest articles